Startups
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
Overview
Location
United States, Texas, Plano
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 9, 2026 | Three Swiss biotechs advance fertility, cancer and neuro programmes | ReproNovo, a Lausanne-based clinical-stage biopharmaceutical company founded in 2021, has dosed the first participant in NORDIC, a European Phase 2 trial of its candidate RPN-002. The randomised, placebo-controlled, double-blind study will... |
| Jul 1, 2026 | EIB Grants Orano €125 Million Loan To Finance Orano Med Innovations And Infrastructure | The European Investment Bank and Orano announced the signing of a €125 million credit line to finance the development of Orano Med and its industrial infrastructure. The financing will notably support the construction of the Advanced Thoriu... |
| Dec 1, 2025 | Molecular Partners: Pioneering Targeted Radiopharmaceuticals | 01.12.2025 10:30, Rita Longobardi Founded in 2004 as a spin-off from the University of Zurich, Molecular Partners, a Roadshow Partner of Venture Leaders Biotech, has spent two decades developing DARPin-based therapeutics designed to address... |
| Orano Med |
Reviews 0
FAQ about Orano Med
What has the press written about Orano Med?
Parsers VC has collected 5 articles mentioning Orano Med, among them “Three Swiss biotechs advance fertility, cancer and neuro programmes” (Jul 9, 2026) and “EIB Grants Orano €125 Million Loan To Finance Orano Med Innovations And Infrastructure” (Jul 1, 2026).
Is Orano Med still active?
Yes, Orano Med is active; its latest activity on Parsers VC dates from Oct 29, 2026.